March 21, 2018 / 4:49 PM / a month ago

BRIEF-FDA Approves Roche's Lucentis prefilled syringe For Diabetic Macular Edema, Diabetic Retinopathy

March 21 (Reuters) - Roche Holding Ag:

* FDA APPROVES GENENTECH’S LUCENTIS (RANIBIZUMAB INJECTION) 0.3 MG PREFILLED SYRINGE FOR DIABETIC MACULAR EDEMA AND DIABETIC RETINOPATHY

* GENENTECH - LUCENTIS 0.3 MG PFS IS EXPECTED TO BE AVAILABLE IN Q2 OF 2018

* GENENTECH - PREFILLED SYRINGE OPTIONS ARE NOW FDA-APPROVED FOR ALL LUCENTIS INDICATIONS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below